Lourdes Salazar-Huayna

A mouse PDX clinical trial reveals broad efficacy of niraparib and vc-seco-DUBA anti-HER2 ADC SYD985 in HER2/neu expressing endometrial cancer

Cristian P. Moiola, Carlos López-Gil, Marta Rebull, Ana M. Sotoca et autres

INTRODUCTION: Advanced and recurrent high-risk endometrial cancer (EC) frequently develops resistance to platinum-based chemotherapy, leaving patients with limited therapeutic options. Recent studies have shown that HER2 expression spans a broad spectrum of endometrial cancers, extending beyond HER2-amplified tumors, while functional homologous recombination …

es, nl, ps (code pays fourni par la source)

HPV Methylation as a Marker of Progression to High-Grade Squamous Intraepithelial Lesions (HSIL) in Patients With Negative Cytology/ASCUS and High-Risk HPV Positive

Lourdes Salazar-Huayna, Úrsula Acosta, María Cristina Centeno Mediavilla, Marta Serra et autres

According to the International Agency for Research on Cancer (IARC), cervical cancer (CC) ranks fourth among the most frequently diagnosed cancers worldwide. Women with negative or atypical cytology (ASCUS) and high-risk human papillomavirus (HR-HPV) infection represent a special group that establishes a …

es, us (code pays fourni par la source)

Segmenting Invasive and In Situ Carcinoma in Breast WSIs with a Pretrained Histopathology Transformer

Lauren Jimenez-Martin, Felip Vilardell, Ana Petit, Eduard Dorca et autres

es (code pays fourni par la source)

Extrapulmonary lymphangioleiomyomatosis: an incidental finding detected in surgery for gynecological malignancies

Lourdes Salazar-Huayna, Giulio Bonaldo, Ana Luzarraga Aznar, Martina Aida Ángeles

es (code pays fourni par la source)

Impact Of The FIGO 2023 Staging System On Patients With Endometrial Cancer

Giulio Bonaldo, Vicente Bebia, Lourdes Salazar-Huayna, Ana Luzarraga-Aznar et autres

es (code pays fourni par la source)

Molecular classification improves preoperative risk assessment of endometrial cancer

Silvia Cabrera, Vicente Bebia, Carlos López-Gil, Ana Luzarraga-Aznar et autres

es, Tunisie (code pays fourni par la source)

564 Molecular profile may preoperatively predict extrauterine spread in endometrial cancer patients: a retrospective analysis

Vicente Bebia, Carlos López-Gil, Ana Luzarraga-Aznar, Melek Denizli et autres

es (code pays fourni par la source)

Molecular profile is a strong predictor of the pattern of recurrence in patients with endometrial cancer

Ana Luzarraga Aznar, Vicente Bebia, Carlos López-Gil, Beatriz Villafranca-Magdalena et autres

es (code pays fourni par la source)

Supplementary Figure from A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors

Juana Fernández‐Rodríguez, Edgar Creus‐Bachiller, Xiaohu Zhang, María Martínez‐Iniesta et autres

Supplementary Figure from A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors

Data from A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors

Juana Fernández‐Rodríguez, Edgar Creus‐Bachiller, Xiaohu Zhang, María Martínez‐Iniesta et autres

Abstract Malignant peripheral nerve sheath tumors (MPNST) are soft-tissue sarcomas that are the leading cause of mortality in patients with Neurofibromatosis type 1 (NF1). Single chemotherapeutic agents have shown response rates ranging from 18% to 44% in clinical trials, so there is …

Supplementary Table from A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors

Juana Fernández‐Rodríguez, Edgar Creus‐Bachiller, Xiaohu Zhang, María Martínez‐Iniesta et autres

Supplementary Table from A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors

Supplementary Table from A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors

Juana Fernández‐Rodríguez, Edgar Creus‐Bachiller, Xiaohu Zhang, María Martínez‐Iniesta et autres

Supplementary Table from A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors